Status:
COMPLETED
Patterns of Use of Belatacept: Analysis of Data From the Collaborative Transplant Study
Lead Sponsor:
Bristol-Myers Squibb
Collaborating Sponsors:
Heidelberg University
Conditions:
Transplantation, Organ
Eligibility:
All Genders
18+ years
Brief Summary
The primary purpose is to describe the pattern of Belatacept use at the time of transplant and up to three years post-transplantation for all Belatacept treated patients.
Detailed Description
Time Perspective: Prospective design, Retrospective data collection and analysis
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients who received solid organ transplantation during study period in one of the transplant centers involved in CTS
Exclusion
Key Trial Info
Start Date :
March 31 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2018
Estimated Enrollment :
72392 Patients enrolled
Trial Details
Trial ID
NCT01476943
Start Date
March 31 2012
End Date
April 30 2018
Last Update
May 4 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.